Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab in High-Risk Smoldering Multiple Myeloma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-3470
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

A Phase II, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

Eptinezumab in Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study (PROMISE-1)

Cephalalgia
MedicineNeurology
2020English

ADHD and EEG-neurofeedback: A Double-Blind Randomized Placebo-Controlled Feasibility Study

Journal of Neural Transmission
PsychiatryMental HealthNeurologyBiological Psychiatry
2010English

Effects of Fenofibrate on Albuminuria in Patients With Hypertriglyceridemia and/or Hyperuricemia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Study

Current Therapeutic Research
Pharmacology
2003English

Randomized, Double Blind, Placebo-Controlled Study on Long-Term Prophylaxis With Echinacea Purpurea

Reviews on Clinical Pharmacology and Drug Therapy
2012English

Subcutaneous Immunoglobulin for Maintenance Treatment in Chronic Inflammatory Demyelinating Polyneuropathy - A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial: The PATH Study

Muscle and Nerve
Molecular NeuroscienceNeurologyPhysiologyCellular
2017English

Different Inhaler Devices in Acute Asthma Attacks: A Randomized, Double-Blind, Placebo-Controlled Study

Jornal de Pediatria
Child HealthPediatricsPerinatology
2005English

Randomized, Double-Blind, Placebo-Controlled Trial of Monthly Versus Bimonthly Dihydroartemisinin-Piperaquine Chemoprevention in Adults at High Risk of Malaria

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2012English

Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Lipegfilgrastim in Patients With Non-Small Cell Lung Cancer Receiving Myelosuppressive Therapy

SpringerPlus
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy